Alexion Pharmaceuticals

• Archives
• Highlights
• Media Kit
• Inquiries

Press Releases

• Alexion to Present at the Cowen and Company 30th Annual Health Care Conference

  Tuesday, March 2, 2010

• Alexion Joins NORD, EURORDIS and Other Patient Advocacy Groups in Supporting the Goals of Rare Disease Day 2010

  Friday, February 26, 2010

• Alexion Appoints Andreas Rummelt to its Board of Directors

  Wednesday, February 24, 2010

• Alexion Reports Fourth Quarter and Full Year 2009 Results

  Thursday, February 11, 2010

• Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2009 Results on February 11, 2010

  Thursday, January 28, 2010

• Alexion to Present at the 28th Annual JP Morgan Healthcare Conference

  Wednesday, January 6, 2010

• Soliris^® Reduced Hemolysis, Lowered Thrombosis Rate and Improved Quality of Life in Patients with PNH Who Had Previously Never Been Transfused

  Monday, December 7, 2009

• Soliris^® Reversed Thrombocytopenia in Patients with Both PNH and Pre-Existing Thrombocytopenia in Study Presented at ASH Annual Meeting

  Monday, December 7, 2009

• Soliris^® Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow Insufficiency Disorders

  Sunday, December 6, 2009

• Researchers Report Clinical Association Between Type II PNH Cells and Thrombocytopenia

  Sunday, December 6, 2009